DK0526566T3 - Behandling af erektil dysfunktion - Google Patents

Behandling af erektil dysfunktion

Info

Publication number
DK0526566T3
DK0526566T3 DK91909083T DK91909083T DK0526566T3 DK 0526566 T3 DK0526566 T3 DK 0526566T3 DK 91909083 T DK91909083 T DK 91909083T DK 91909083 T DK91909083 T DK 91909083T DK 0526566 T3 DK0526566 T3 DK 0526566T3
Authority
DK
Denmark
Prior art keywords
agent
erectile dysfunction
agents include
agents
treatment
Prior art date
Application number
DK91909083T
Other languages
English (en)
Inventor
Virgil A Place
Robert M Gale
Randall G Berggren
Original Assignee
Vivus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vivus Inc filed Critical Vivus Inc
Application granted granted Critical
Publication of DK0526566T3 publication Critical patent/DK0526566T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41—Devices for promoting penis erection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/16—Male reproductive, genital organs
    • A61M2210/167—Penis
DK91909083T 1990-04-25 1991-04-22 Behandling af erektil dysfunktion DK0526566T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51439790A 1990-04-25 1990-04-25
PCT/US1991/002758 WO1991016021A1 (en) 1990-04-25 1991-04-22 Treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
DK0526566T3 true DK0526566T3 (da) 1999-08-09

Family

ID=24046960

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91909083T DK0526566T3 (da) 1990-04-25 1991-04-22 Behandling af erektil dysfunktion

Country Status (16)

Country Link
EP (1) EP0526566B1 (da)
JP (1) JP3477197B2 (da)
KR (1) KR0169950B1 (da)
AT (1) ATE173603T1 (da)
AU (1) AU655420B2 (da)
CA (2) CA2040914C (da)
DE (1) DE69130529T2 (da)
DK (1) DK0526566T3 (da)
ES (1) ES2124225T3 (da)
FI (1) FI104946B (da)
IE (1) IE81089B1 (da)
NO (1) NO300083B1 (da)
NZ (2) NZ237899A (da)
PT (1) PT97441B (da)
WO (1) WO1991016021A1 (da)
ZA (1) ZA912984B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981593A (en) * 1991-07-03 1999-11-09 Scott; Nathan Earl Prostaglandin E2 treatment of impotence
US6291528B1 (en) 1991-07-03 2001-09-18 Nathan Earl Scott Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal
US5962528A (en) * 1991-07-03 1999-10-05 Scott; Nathan Earl Prostaglandin E2 /F2α combination for treating impotence
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
CZ278497A3 (cs) * 1995-03-14 1998-04-15 Vivus, Incorporated Způsob a sestava zařízení k prevenci impotence
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
US5855548A (en) * 1996-06-14 1999-01-05 Vivus, Incorporated Venous flow control element for maintaining penile erection
GR1002847B (el) 1997-05-06 1998-01-27 Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US5925629A (en) * 1997-10-28 1999-07-20 Vivus, Incorporated Transurethral administration of androgenic agents for the treatment of erectile dysfunction
US5919474A (en) * 1997-10-28 1999-07-06 Vivus, Inc. Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
CN1282249A (zh) * 1997-12-18 2001-01-31 内森·厄尔·斯科特 用于治疗阳痿和增强性唤起的前列腺素E2/F2α组合剂
ES2155740B1 (es) * 1998-03-31 2001-12-01 Vita Invest Sa Dispositivo intrauretral para el tratamiento de la disfuncion erectil.
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
AU1414200A (en) * 1998-12-02 2000-06-19 Mochida Pharmaceutical Co., Ltd. Preparations for intraurethral administration
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US7176238B1 (en) 1999-03-01 2007-02-13 Nitromed Inc. Nitrostated and nitrosylated prostaglandins, compositions and methods of use
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US7105571B2 (en) 2000-01-10 2006-09-12 Nexmed Holdings, Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
US6693135B2 (en) 2000-01-10 2004-02-17 Nexmed (Holdings) Incorporated Prostaglandin compositions and methods of treatment for male erectile dysfunction
GR1004266B (el) * 2001-04-30 2003-06-18 Ηλιας Κ. Παπαδοπουλος Φαρμακευτικο παρασκευασμα για την διαγνωση και θεραπεια της στυτικης δυσλειτουργιας
KR20090121315A (ko) 2007-02-12 2009-11-25 디엠아이 바이오사이언시스 인코포레이티드 조루 및 발기부전을 동시에 치료하는 방법
PL2114147T3 (pl) 2007-02-12 2012-10-31 Vyrix Pharmaceuticals Inc Zmniejszanie skutków ubocznych tramadolu
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
CA2973096A1 (en) 2015-01-06 2016-07-14 Cardiovascular Biotherapeutics, Inc. Angiogenic treatment of ischemic heart disease
AU2016220304B2 (en) * 2015-02-16 2019-07-25 Venturis Therapeutics, Inc. Therapeutic angiogenesis for treating erectile conditions
US10653549B2 (en) * 2017-07-18 2020-05-19 Carl W. Lange, IV Topical medication method for erectile dysfunction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1897423A (en) * 1928-10-30 1933-02-14 Ferri Filiberto Device for preventing gonorrhea infection
US4829991A (en) * 1987-01-06 1989-05-16 Medical Engineering Corp. Method and device for stimulating an erection
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
IT1221826B (it) * 1988-06-08 1990-07-12 Medico Harvey Srl Centro Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IL87055A (en) * 1988-07-08 1994-06-24 Illana Gozes Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
DE3913954A1 (de) * 1989-04-27 1990-10-31 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen

Also Published As

Publication number Publication date
EP0526566B1 (en) 1998-11-25
KR0169950B1 (ko) 1999-01-15
FI104946B (fi) 2000-05-15
CA2040914C (en) 2001-12-04
NO924032L (no) 1992-10-26
IE81089B1 (en) 2000-03-08
NZ237899A (en) 1997-03-24
WO1991016021A1 (en) 1991-10-31
CA2352552C (en) 2008-12-02
EP0526566A1 (en) 1993-02-10
KR930700048A (ko) 1993-03-13
ES2124225T3 (es) 1999-02-01
FI924817A0 (fi) 1992-10-23
ZA912984B (en) 1992-01-29
AU655420B2 (en) 1994-12-22
NZ270871A (en) 1999-05-28
FI924817A (fi) 1992-10-23
ATE173603T1 (de) 1998-12-15
PT97441A (pt) 1992-05-29
CA2040914A1 (en) 1991-10-26
NO924032D0 (no) 1992-10-19
CA2352552A1 (en) 1991-10-26
DE69130529T2 (de) 1999-06-02
DE69130529D1 (de) 1999-01-07
JPH05506800A (ja) 1993-10-07
PT97441B (pt) 1998-08-31
JP3477197B2 (ja) 2003-12-10
IE911330A1 (en) 1991-11-06
AU7856391A (en) 1991-11-11
NO300083B1 (no) 1997-04-07

Similar Documents

Publication Publication Date Title
DK0526566T3 (da) Behandling af erektil dysfunktion
SE8803087L (sv) Ett nytt saett foer behandling av erektil dysfunktion
EA200001043A3 (ru) Соединения для лечения женской сексуальной дисфункции
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
MX9204381A (es) Metodo para tratar inflamacion ocular
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
MX9202279A (es) Combinaciones de agentes antivirales.
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
KR920016088A (ko) 하부 요로 질환의 치료
DK0549660T3 (da) Forøgelse af glutathionniveauer med glutamin
BR9809571A (pt) Composição medicinal e processo para produzì-la
KR950016760A (ko) 치질 치료제
JP2003501345A5 (da)
DE69315396T2 (de) Wegwerfwindel
ATE141506T1 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
IT1247678B (it) Metodo per la cura dell'impotenza erettiva maschile
KR880004810A (ko) 소화성 궤양 치료제
BR9609868A (pt) Conjugado sintético de uma proteína e uma pluralidade de epítopos para uso em medicina processos para evitar a rejeição de um xenoenxerto ou pelo menos reduzir a extensão ou taxa de rejeição para tratar uma doença e sangue removido de um doador de sangue aparelho sangue composição farmaceuticamente aceitável e uso de um conjugado
RU99103105A (ru) Способ лечения вторичной глаукомы
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin
SE8904384D0 (sv) Pharmaceutical composition